Advertisement
Advertisement

LTRN

LTRN logo

Lantern Pharma Inc. Common Stock

3.95
USD
Sponsored
+0.12
+3.13%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

3.95

0.00
+0.10%

Lantern Pharma Inc. Common Stock Profile

About

Lantern Pharma Inc.is a biotechnology company. It develops medicines for multi-drug treatment resistance cancers focusing on prostate and ovarian cancers. The company's drug candidate consist LP-100, LP-300 and LP-184 which are in clinical stage. Lantern Pharma Inc.is based in Dallas, Texas.

Info & Links

CEO

Panna Sharma

Headquarters

1920 MCKINNEY AVENUE, 7TH FLOOR
DALLAS, TX 75201, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.lanternpharma.com

Auditor

EisnerAmper LLP

Share holders

12

Employees

16

Lantern Pharma Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

50.45M

Enterprise Value

45.53M

Enterprise Value/EBITDA(ttm)

-2.71

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.20

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-150.76%

Return on Invested Capital(ttm)

-167.56%

Return on Assets(ttm)

-108.38%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-16.79M

Net Income Available to Common(ttm)

-15.91M

Diluted EPS(ttm)

-1.57

Share Statistics

Beta (5Y Monthly)

1.75

52-Week Change

28.66%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

11.30M

Dividend Yield

0.00%

Float4

10.30M

% Held by Insiders

8.50%

% Held by Institutions

28.62%

Balance Sheet

Total Cash(mrq)

6.32M

Total Cash Per Share(mrq)

0.56

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.40%

Quick Ratio(mrq)

2.40%

Book Value Per Share(mrq)

0.58

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.44

Free Cash Flow(ytd)

-15.68M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement